Please login to the form below

Not currently logged in
Email:
Password:

Adobe CEO joins Pfizer board

Shantanu Narayen joins corporate governance and science and technology committees

Pfizer Shantanu NarayenThe CEO of software giant Adobe Systems has joined pharma company Pfizer as a member of its board of directors.

Shantanu Narayen has been CEO of Adobe since 2007, having previously served as chief operating officer, executive VP of worldwide products and senior VP of product development at the company, which markets products such as PhotoShop and Acrobat.

He joins the corporate governance and science and technology committees of Pfizer's board and will use his background in technology to guide Pfizer's strategy going forward.

“The addition of Shantanu Narayen to our board helps ensure that Pfizer will continue to benefit from a diversity of experience,” said Ian Read, Pfizer's chairman and CEO.

In addition to his role at Adobe, Narayen is a member of the US President's management advisory board; a director of computer company Dell and president of the Adobe Foundation, which funds philanthropic initiatives around the world.

4th October 2013

From: Sales, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...